ASCENDIS PHARMA A/S
CVR 29918791 · Public limited company (A/S) · Active · Low risk
ASCENDIS PHARMA A/S is a Public limited company (A/S), founded on , based in Hellerup. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 19 annual reports have been published. CEO: Scott Thomas Smith, Michael Wolff Jensen, Anni Lotte Kirstine Pedersen.
Bankruptcy risk for ASCENDIS PHARMA A/S
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 29918791
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (20 years)
- Address
- Tuborg Boulevard 12
2900 Hellerup - Municipality
- Gentofte
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 66.4m
- Employees
- 108 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 19 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 5 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 224 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|
Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 90 | ||
| 1 Jan 2024 – 31 Dec 2024 | 150 | ||
| 1 Jan 2023 – 31 Dec 2023 | 165 | ||
| 1 Jan 2022 – 31 Dec 2022 | 156 | ||
| 1 Jan 2021 – 31 Dec 2021 | 174 | ||
| 1 Jan 2020 – 31 Dec 2020 | 172 | ||
| 1 Jan 2019 – 31 Dec 2019 | 156 | ||
| 1 Jan 2018 – 31 Dec 2018 | 154 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 153 | ||
| 1 Jan 2014 – 31 Dec 2014 | 128 | ||
| 1 Jan 2013 – 31 Dec 2013 | 167 | ||
| 1 Jan 2012 – 31 Dec 2012 | 155 | ||
| 1 Jan 2011 – 31 Dec 2011 | 152 | ||
| 1 Jan 2010 – 31 Dec 2010 | 156 | ||
| 1 Jan 2009 – 31 Dec 2009 | 153 | ||
| 1 Jan 2008 – 31 Dec 2008 | 155 | ||
| 21 Sep 2006 – 31 Dec 2007 | 163 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Scott Thomas Smith | Current | |
| CEO | Michael Wolff Jensen | Current | |
| CEO | Anni Lotte Kirstine Pedersen | Current | |
| CEO | Thomas Paul Soloway | ||
| Board | Jan Møller Mikkelsen | Current | |
| Board | Lisa Jane Morrison | Current | |
| Board | Lars Holtug | Current | |
| Board | Albert Cha | Current | |
| Board | Siham Imani | Current | |
| Board | William Carl Fairey Jr | Current | |
| Board | Jean-Jacques Bienaime | Current | |
| Board | Dirk Kersten | ||
| Board | Michael Gerhard Mayer | ||
| Board | Michael Wolff Jensen | ||
| Board | Rafaèle Elisabeth Tordjman | ||
| Board | William Robert Ringo | ||
| Board | Martin Olin | ||
| Board | Edwin William de Graaf | ||
| Board | Jonathan Silverstein | ||
| Board | Jim Healy | ||
| Board | Albert Cha | ||
| Board | Birgitte Volck | ||
| Board | Rafaèle Tordjman | ||
| Owner (90%) | Cede & Co | Current | |
| Owner (5%) | Zweite TechnoStart Ventures Fonds GmbH & Co. KG i.L. | ||
| Owner (5%) | OrbiMed Private Investments V, LP | ||
| Owner (20%) | SOFINNOVA PARTNERS | ||
| Owner (5%) | Sofinnova Venture Partners IX, L.P | ||
| Owner (33%) | BNY Nominees Ltd. | ||
| Owner (67%) | BNY Nominees Ltd. | ||
| Owner (90%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | DELOITTE HOLDING STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Founder | Jan Møller Mikkelsen | Current |
The CEOs' other companies
Michael Wolff Jensen – 21 other companies, of which 6 bankrupt
- EMF ENVIROTEC A/S Bankrupt 24 Mar 2010
- NETWORKLEAGUE A/S Bankrupt 31 Jan 2002
- PARADIS INTERNATIONAL A/S Bankrupt 24 May 2023
- PDK A/S Bankrupt 2 Mar 2023
- TOUCHDIVA EUROPE A/S Bankrupt 26 Mar 2010
- UNWIREDFACTORY A/S Bankrupt 19 Feb 2004
- ASCENDIS PHARMA BONE DISEASES A/S Active
- ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S Active
- AZANTA A/S Active
- Ascendis Pharma Endocrinology Division A/S Active
- Ascendis Pharma Europe A/S Active
- Ascendis Pharma Growth Disorders A/S Active
- Ascendis Pharma Nordics A/S Opløst
- Ascendis Pharma Oncology Division A/S Active
- Custimoo ApS Active
- EMF INDUSTRIES A/S Compulsorily dissolved
- GENMAB A/S Active
- PARADIS GROUP ApS Fusioneret
- TECH GROWTH INVEST ApS Active
- VANX ApS Opløst
- VELOXIS PHARMACEUTICALS A/S Active
Anni Lotte Kirstine Pedersen – 9 other companies
- ACADIA PHARMACEUTICALS A/S Active
- ASCENDIS PHARMA BONE DISEASES A/S Active
- ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S Active
- Ascendis Pharma Endocrinology Division A/S Active
- Ascendis Pharma Europe A/S Active
- Ascendis Pharma Growth Disorders A/S Active
- Ascendis Pharma Nordics A/S Opløst
- Ascendis Pharma Oncology Division A/S Active
- PROCESS DESIGN A/S Active
Address history (3 moves)
| Tuborg Boulevard 12, 2900 Hellerup | |
| Tuborg Boulevard 5, 2900 Hellerup | |
| Tuborg Boulevard 12, 2900 Hellerup | |
| Soløsevej 24, 2820 Gentofte |
Former names
| ASCENDIS PHARMA A/S | – now |
| ASCENDIS PHARMA ApS | – |
| CADENZA PARTNERS ApS | – |
Employees per year
Other companies at the same address
- AFV-SELSKABET AF 8. JULI 2009 ApS Bankrupt
- AFVIKLINGSSELSKABET AF DEN 8. MAJ 2006 ApS Bankrupt
- AFVIKLINGSSELSKABET AF DEN 8. MAJ 2006 HOLDINGS ApS Bankrupt
- ANPARTSSELSKABET 11. MAJ 2006 Bankrupt
- ANPARTSSELSKABET AF 3.2.2004 Bankrupt
- All about IT Europe ApS Bankrupt
- ApS AF 9. NOVEMBER 2006 GENTOFTE Bankrupt
- B18 DANMARK ApS Bankrupt
- BROBY OVERDREV, EJENDOMSANPARTSSELSKAB Bankrupt
- BogM IT ApS Bankrupt
- Boligfonden LIAB ApS Bankrupt
- Brdr. Daugaard ApS Bankrupt
- Bygge Mester ApS Bankrupt
- CAMANN ApS Bankrupt
- CARCARE-EUROPE ApS Bankrupt
- CCE CAPITAL S.M.B.A. Bankrupt
- CID ApS Bankrupt
- CONSULTING LEAGUE ADVISORY ApS Bankrupt
- Clear Quality Holding IVS Bankrupt
- DK Accounting ApS Bankrupt
- DK Legal Advice ApS Bankrupt
- DKL 13 ApS Bankrupt
- DKL 15 ApS Bankrupt
- DKL 16 ApS Bankrupt
- DKL 17 ApS Bankrupt
Similar companies in Gentofte
- Lica Pharma ApS Hellerup
- SKN computation ApS Gentofte
- WinQure Medicine ApS Klampenborg
- Illum Biotech ApS Charlottenlund
- Novo Nordisk Clinical Innovation Centre A/S Gentofte
- Bollværk ApS Hellerup
- Epitopea ApS Klampenborg
- Spectoceutics ApS Gentofte
- CENEXUM Technologies ApS Gentofte
- Protein Frontiers ApS Gentofte
- ClinOption ApS Dyssegård
- Ascendis Pharma Oncology Division A/S Hellerup
Questions and answers about ASCENDIS PHARMA A/S
Has ASCENDIS PHARMA A/S gone bankrupt?
No, ASCENDIS PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ASCENDIS PHARMA A/S?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of ASCENDIS PHARMA A/S?
Scott Thomas Smith, Michael Wolff Jensen, Anni Lotte Kirstine Pedersen are the CEOs of ASCENDIS PHARMA A/S.
Who is the auditor of ASCENDIS PHARMA A/S?
ASCENDIS PHARMA A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was ASCENDIS PHARMA A/S founded?
ASCENDIS PHARMA A/S was founded on 21 September 2006.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.